Advocates Pharmaceutical & Healthcare
Founded in 2002, Advocates Ltd., Pharmaceutical & Healthcare is a global Contract Development Services Organisation (CDSO), based in Hong Kong, USA and Scotland.
Almac provides a comprehensive range of integrated services from research through to commercialisation. Almac is a financially stable, privately owned organisation with over 3,300 employees located within the US and UK. Over 95% of work is repeat business, testament itself to the quality, innovation, efficiency and the high level of customer satisfaction provided.
Almac’s integrated solutions extend from research to commercialisation and include:
Biomarker Discovery & Development:
· Companion Diagnostic Development
· Genomic Services
· Bioinformatics Consultancy
· Proprietary Discovery Arrays
API Services & Chemical Development:
· API Development & Manufacture
· Peptide & Protein Technology
· Accelerated First in Man Solution
· Solid State Services
· Isotope Chemistry
· Preformulation & Early Stage Development
· Scale Up and Late Stage Development
· Clinical Trial Manufacture
· Contained Development & Manufacture
· Physical & Chemical Characterisation
· Method Development & Validation
· API & Drug Product Testing
· Stability Testing
Clinical Trial Supply:
· Comparator Blinding
· Packaging & Labelling
· QP Release
· Global Distribution & Supply Chain Management
· IVR / Web
· Statistical Services
· Manufacturing & Packaging
· Product Launch & Distribution
Come and see us at booth #70
Mr Philip Diamond
Mr Colin Hayburn
Mr Hans Glise
Albany Molecular Research, Inc. (AMRI) is a global contract research and manufacturing organization offering customers fully integrated drug discovery, development, and manufacturing services.
For over 21 years AMRI has demonstrated its adaptability as the pharmaceutical and biotechnology industries have undergone tremendous change in response to multiple challenges. This experience, a track record of success and locations in the United States, Europe and Asia now provides our customers with SMARTSOURCINGTM, a full range of value-added opportunities providing customers informed decision-making, enhanced efficiency and more successful outcomes at all stages of the pipeline.
AMRI has also successfully partnered R&D programs and is actively seeking to out-license its remaining programs for further development.
Aptuit is a global pharmaceutical services company that delivers early to mid-phase drug development solutions to more than 800 companies by applying scientific excellence, outstanding service and a team of some of the foremost scientific professionals in the industry. From seven locations around the world, including our strategic partner in India, Aptuit assists clients by shortening their timelines and delivering on time, in full. We solve scientific problems through technical expertise and superior project management. We provide significant value to our clients by delivering high quality services that exceed regulatory compliance standards.
Aptuit services include:
• Drug Design & Discovery
• Preclinical Biosciences
• API Development and Manufacture
• Solid State Chemistry
• Solid, Oral and Sterile Dosage Form Development and Manufacture
• Clinical Sciences
• Aptuit INDiGO® - Accelerated Drug Development Program
• Integrated Drug Discovery and Development
Aptuit (Glasgow) are specialist providers of formulation development and GMP manufacture of sterile dosage products, both liquid and lyophilised, for use within pre-clinical and clinical trials.
Our dedicated formulation scientists are experts in the delivery of complex formulations for liquid and lyophilised product types for small organic molecules through to large macromolecules (peptides, proteins, oligonucleotides etc). This is supported by a team of dedicated analytical scientist who are able to develop, validate or transfer analytical methods for use in the development of the formulation.
Arecor enables biologics to be more stable; highly-concentrated; and durable to temperature. Arecor has a proprietary and patented technology platform for improving the stability of a range of therapeutic proteins including vaccines.
BIA (UK BioIndustry Association)
Come and see us at booth #73
BioPartner.co.uk is an independent, accredited trade organisation, promoting international partnering for trade, investment and collaborations with UK Life Science companies. BioPartner's UK Delegations promote the UK presence at major international biopharma conferences. Through the BioPartnership Programme, BioPartner assists companies to attend these events by providing access to government grants and heavily discounted entry fees.
Come and see us at booth #73
Cambridge Bioscience is a well established, leading European distributor of life science products bringing new and exciting technologies to researchers. Working with over forty specialist suppliers around the world, we offer an innovative, extensive and diverse range of over 450,000 products, services and instruments supporting research in the areas of drug discovery, regenerative medicine, cell culture and much more.
The products and services Cambridge Bioscience offers includes:
· Ion Channel, GPCR & Kinase Profiling Services
· Primary screening & Secondary Drug Profiling Services
· Cardiac Safety Assessment
· Ion Channel & GPCR Cell Lines
· Human Tissues, TMAs & Biofluids
· Primary Cells & Cell Culture Technologies
To find out more, please meet us at the event or contact us using the details below
Tel: +44 (0)1223 316 855
Fax: +44 (0)1954 781 323
Competitive Drug Development International is an international biotechnology and pharmaceutical consulting company. Unlike a traditional consultancy who talk and advise, our mode of working is hands-on and delivery focused, in addition to the strategic planning. From evidence based protocol feasibility, to management of CROs and CMOs, to delivery of POC, we can achieve your specific objectives quickly and more cost-effectively. Come and see us at Bio-Europe 2012 in Hamburg at booth #27.
Crescendo has developed a novel antibody fragment platform which generates fully human VH products, the smallest antibody fragments, that mature in vivo in a transgenic mouse. The company has a highly experienced antibody drug discovery team and capability. Crescendo is using the platform to develop a portfolio of differentiated medicines, with an initial focus on novel topical products, and is identifying companies interested in partnering this platform during 2013.
Come and see us at booth #73